JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2009, 58(5):203-207

Antimycobacterial activity of novel derivatives of arylcarbonyloxyaminopropanols

S. Kečkéšová1,*, E. Sedlárová1, J. Čižmárik1, V. Garaj1, J. Csöllei2, P. Mokrý2, F. Andriamainty1, I. Malík1, J. Kaustová3
1 Comenius University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Bratislava
2 University of Veterinary and Pharmaceutical Sciences, Faculty of Pharmacy, Institute of Chemical Drugs, Brno
3 Regional Institute of Public Health, Ostrava

The study examined the antimicrobial activity of 2-hydroxy-3-[4-(2-fluoro, 4-fluoro, and 2-metoxyphenyl)-piperazin-1-yl]-propyl-4-[(alkoxycarbonyl)amino] benzoates, their salts with hydrochloric acid, with one to four carbon atoms in the alkoxy group of the carbamoyl group studied and described. The series of these substances were evaluated in vitro against Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium kansasii and against clinically isolated strains of Mycobacterium kansasii 6 509/96. The correlation of this activity with lipophilicity (log k') was used to describe the structure-antimycobacterial activity relationships (QSARs). The tests have shown that practically all the substances under study possess antituberculotic activity. In vitro antimycobacterial activity increased with increasing lipophilicity. According to the obtained results, the substances can be considered as potential antituberculotics.

Keywords: antimycobacterial activity; antituberculotic activity; potential antituberculotics; arylcarbonyloxyaminopropanols; lipophilicity; phenylcarbamates
Grants and funding:

This study was supported by the VEGA grant No. 1/4291/07.

Received: October 5, 2009; Accepted: November 4, 2009; Published: May 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kečkéšová S, Sedlárová E, Čižmárik J, Garaj V, Csöllei J, Mokrý P, et al.. Antimycobacterial activity of novel derivatives of arylcarbonyloxyaminopropanols. Čes. slov. farm. 2009;58(5-6):203-207.
Download citation

References

  1. Čižmárik, J., Waisser, K., Doležal, R., Kaustová, J.: Farm. Obzor, 2007; 76, 144-146.
  2. Mokrý, P., Zemanová, M., Csöllei, J., Račanská, E., Tumová, I.: Pharmazie, 2003; 58, 18-21.
  3. Kečkéšová, S., Sedlárová, E., Csöllei, J., Mokrý, P.: Čes. a Slov. Farm., 2008; 57, 160-164.
  4. Kečkéšová, S., Sedlárová, E., Csöllei, J., Mokrý, P., Vančo, J., Vanko, M.: Acta Facult. Pharm. Univ. Com., 2008; 55, 122-128.
  5. Waisser, K., Dražková, K., Čižmárik, J., Kaustová, J.: Folia Microbiol., 2003; 48, 45-50. Go to original source... Go to PubMed...
  6. Malík, I., Sedlárová, E., Csöllei, J., Andriamainty, F., Čižmárik, J., Kečkéšová, S.: Acta Facult. Pharm. Univ. Com., 2007; 54, 136-145.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.